Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep

Gene Therapy

Volumn 6, Issue 1, 1999, Pages 98-106

  Iwamoto, H S ^a,c   Trapnell, B C ^b   McConnell, C J ^a   Daugherty, C ^a   Whitsett, J A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Fetal therapy; Fetal treatment; Fetus; Gene therapy; Gene transfer

Indexed keywords

BACTERIAL ENZYME; BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; FETUS; FETUS DEATH; GENE DELETION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LUNG FIBROSIS; MORTALITY; NONHUMAN; PERINATAL DEVELOPMENT; PNEUMONIA; PRENATAL EXPOSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SHEEP;

ADENOVIRIDAE; ANIMALS; FEMALE; FETAL DEATH; FETAL DISEASES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GESTATIONAL AGE; INFLAMMATION; INJECTIONS; LUNG; LUNG DISEASES; PREGNANCY; SHEEP;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); DNA VIRUSES; OVIS ARIES;

EID: 0032921771     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300804     Document Type: Article

References (42)

1. Mastrangeli A et al. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest 1993; 91: 225-234.
2. Yei SP et al. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther 1994; 5: 731-744.
3. Lemarchand P, Jones M, Yamada I, Crystal RG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 1993; 72: 1132-1138.
4. Vincent M et al. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995; 6: 1019-1028.
5. Holzinger A et al. Intra-amniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995; 38: 1-7.
6. McCray PB Jr et al. Adenovirus-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 1995; 95: 2620-2632.
7. Simon RH et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 1993; 4: 771-780.
8. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
9. Zsengeller ZK et al. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum Gene Ther 1995; 6: 457-467.
10. Zabner J et al. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 1994; 6: 75-83.
11. Billingham RE, Brent L, Medawar PB. 'Activity acquired tolerance' of foreign cells. Nature 1953; 172: 603-606.
12. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 1992; 89: 2581-2584.
13. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
14. Dosch H-M, Hui MF, Doherty PJ. Development of normal and abnormal immune functions in humans. In: Cooper EL, Nisbet-Brown E (eds). Developmental Immunology. Oxford University Press: Oxford, 1993, pp 452-470.
15. Crombleholme TM, Bianchi DW. In utero hematopoietic stem cell transplantation and gene therapy. Semin Perinatol 1994; 18: 376-384.
16. Flake AW et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. New Engl J Med 1996; 335: 1806-1810.
17. Morris B. The ontogeny and comportment of lymphoid cells in fetal and neonatal sheep. Immunol Rev 1986; 91: 219-233.
18. Zepeda M, Wilson JM. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors. Gene Therapy 1996; 3: 973-979.
19. Takahashi M et al. Long-term correction of bilirubin-UDP-glucurononsyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J Biol Chem 1996; 271: 26536-26542.
20. Kass-Eisler A et al. Circumventing the immune response to adenovirus-mediated gene therapy. Gene Therapy 1996; 3: 154-162.
21. Acsadi G et al. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Gen 1994; 3: 579-584.
22. Tripathy SK et al. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci USA 1994; 91: 11557-11561.
23. Walter J et al. Successful expression of human factor IX following repeat administration of an adenoviral vector in mice. Proc Natl Acad Sci USA 1996; 93: 3056-3061.
24. Haynes BF, Denning SM. Lymphopoiesis. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds). The Molecular Basis of Blood Diseases, 2nd edn. WB Saunders: Philadelphia, 1994, pp 425-462.
25. Mackay CR, Maddox JF, Brandon MR. Thymocyte subpopulations during early fetal development in sheep. J Immunol 1986; 136: 1592-1599.
26. Haynes BF, Heinly CS. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med 1995; 181: 1445-1458.
27. Silverstein AM, Prendergast RA, Kraner KL. Fetal response to antigenic stimulus IV. Rejection of skin homografts by the fetal lamb. J Exp Med 1964; 119: 955-964.
28. Zanjani ED et al. Engraftment and long-term expression of human fetal hemapoietic stem cells in sheep following transplantation in utero. J Clin Invest 1992; 89: 1178-1188.
29. Neiderhuber JE, Shermeta D, Turcotte JG, Gikas PW. Kidney transplantation in the foetal lamb. Transplantation 1971; 12: 161-166.
30. Osburn BI, Hoskins RK. Antibody responses to Brucella ovis in maternal and foetal sheep. J Infect Dis 1969; 119: 267-272.
31. Silverstein AM, Uhr JW, Kraner KL. Fetal response to antigenic stimulus. II. Antibody production by the fetal lamb. J Exp Med 1963; 117: 799-812.
32. Sekhon HS, Larson JE. In utero gene transfer into the pulmonary epithelium. Nature Med 1995; 1: 1201-1203.
33. Olver RE, Schneeburger EE, Walters DV. Epithelial solute permeability, ion transport and tight junction morphology in the developing lung of the fetal lamb. J Physiol 1981; 315: 395-412.
34. Teramoto S et al. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum Gene Ther 1995; 6: 1045-1053.
35. Adesanya MR, Redman RS, Baum BJ, O'Connell BC. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum Gene Ther 1996; 7: 1085-1093.
36. Blaiset MA, Couto CG, Evans KL, Smeak DD. Complications of indwelling, silastic central venous access catheters in dogs and cats. J Am Animal Hosp Assoc 1995; 31: 379-384.
37. Miyasaka M, Morris B. The ontogeny of the lymphoid system and immune responsiveness in sheep. Prog Vet Microbiol Immunol 1988; 4: 21-55.
38. Todd L, Mullen M, Olley PM, Rabinovitch M. Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Pediatr Res 1985; 19: 731-737.
39. Massaro D et al. Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest 1985; 76: 1297-1305.
40. Northway WH et al. Late pulmonary sequelae of bronchopulmonary dysplasia. New Engl J Med 1990; 323: 1793-1799.
41. Trapnell BC et al. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci USA 1991; 88: 6565-6569.
42. Hierholzer J, Bingham P. Vero microcultures for adenovirus neutralization tests. J Clin Micro 1978; 7: 499-506.